Advanced search
Start date
Betweenand


Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease

Full text
Author(s):
Singulani, Monique Patricio ; Ferreira, Ana Flavia Fernandes ; Figueroa, Paulina Sepulveda ; Cuyul-Vasquez, Ivan ; Talib, Leda Leme ; Britto, Luiz Roberto ; Forlenza, Orestes Vicente
Total Authors: 7
Document type: Journal article
Source: AGEING RESEARCH REVIEWS; v. 95, p. 20-pg., 2024-02-24.
Abstract

The role of lithium as a possible therapeutic strategy for neurodegenerative diseases has generated scientific interest. We systematically reviewed and meta-analyzed pre-clinical and clinical studies that evidenced the neuroprotective effects of lithium in Alzheimer's (AD) and Parkinson's disease (PD). We followed the PRISMA guidelines and performed the systematic literature search using PubMed, EMBASE, Web of Science, and Cochrane Library. A total of 32 articles were identified. Twenty-nine studies were performed in animal models and 3 studies were performed on human samples of AD. A total of 17 preclinical studies were included in the meta-analysis. Our analysis showed that lithium treatment has neuroprotective effects in diseases. Lithium treatment reduced amyloid-beta and tau levels and significantly improved cognitive behavior in animal models of AD. Lithium increased the tyrosine hydroxylase levels and improved motor behavior in the PD model. Despite fewer clinical studies on these aspects, we evidenced the positive effects of lithium in AD patients. This study lends further support to the idea of lithium's therapeutic potential in neurodegenerative diseases. (AU)

FAPESP's process: 20/02109-3 - Involvement of TRPM2 channel in neurodegeneration and microglial activation in a Parkinson's Disease model induced by 6-hydroxydopamine
Grantee:Ana Flávia Fernandes Ferreira
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 18/07366-4 - Purine and kinin receptors as targets of study and therapeutic interventions in neurological diseases
Grantee:Alexander Henning Ulrich
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 21/06378-1 - Analysis of the involvement of lithium in mitochondrial markers in Alzheimer's Disease
Grantee:Monique Patricio Singulani
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 14/50873-3 - INCT 2014: National Institute of Biomarkers in Neuropsychiatry
Grantee:Wagner Farid Gattaz
Support Opportunities: Research Projects - Thematic Grants